Wire Stories
EpimAb Biotherapeutics Appoints Jerry Su, Ph.D. as Chief Technology Officer
SHANGHAI–(BUSINESS WIRE)–EpimAb Biotherapeutics, a clinical stage biotech company specializing in bispecific antibodies, today announced the appointment of Jerry Su, Ph.D. as the...